Nordette Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Adverse reactions are listed in the Table per CIOMS frequency categories: Very Common: ≥10%; Common: ≥1% and <10%; Uncommon: ≥0.1% and <1%; Rare: ≥0.01% and <0.1%; Very rare: <0.01%.
Use of COCs has been associated with increased risk of the following: Arterial and venous thrombotic and thromboembolic events, including myocardial infarction, stroke, transient ischemic attack, venous thrombosis and pulmonary embolism.
Cervical intraepithelial neoplasia and cervical cancer.
Breast cancer diagnosis.
Benign hepatic tumors (e.g., focal nodular hyperplasia, hepatic adenoma).
See also Special warnings under Warnings and Precautions.
(See table.)

Click on icon to see table/diagram/image

View ADR Monitoring Form

Nordette Adverse Reactions

ethinylestradiol + levonorgestrel

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma